Profil
Tess Cameron is a Principal, Strategic Finance at RA Capital Management.
Tess’s primary responsibility is to partner with our portfolio companies as a strategic finance advisor.
Tess comes to RA from Foghorn Therapeutics, where she was Head of Finance.
Prior to Foghorn, Tess held finance leadership roles at Wave Life Sciences, where she was responsible for FP&A and corporate finance, and Biogen, where she was the finance lead for the CMO and the neurodegeneration portfolio.
Prior to joining biotech/pharma, she was a specialist in the corporate finance team at McKinsey &Co, focused on corporate transactions.
Tess has a BA with a double major in Economics and Peace & Conflict studies from the University of Toronto, Canada.
Aktiva positioner av Tess Cameron
| Företag | Position | Start |
|---|---|---|
| RESEARCH ALLIANCE CORP. II | Finansdirektör/CFO | 2020-07-17 |
RA Capital Management LP (Private Equity)
RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of healthcare and life sciences. It provides financing for pre-seed, seed stage, early stage and growth capital requirements . The firm acts as a lead and co-investor, makes follow-on investments and has a board seat requirement. | Företagsledare/Principal | 2020-06-01 |
Avilar Therapeutics, Inc.
Avilar Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops covalent drugs to treat cancer and other autoimmune diseases | Direktör/Styrelseledamot | 2020-10-01 |
Medical Microinstruments SpA
Medical Microinstruments SpA Medical SpecialtiesHealth Technology Develops and manufactures surgical micro-instruments | Direktör/Styrelseledamot | 2022-07-20 |
Nodexus, Inc.
Nodexus, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company which commercializing the one platform to address widespread unmet needs | Direktör/Styrelseledamot | - |
Research Alliance Holdings II LLC | Företagsledare/Principal | - |
Tidigare kända positioner av Tess Cameron
| Företag | Position | Slut |
|---|---|---|
| CYTEK BIOSCIENCES, INC. | Direktör/Styrelseledamot | 2022-06-01 |
| FOGHORN THERAPEUTICS INC. | Företagsledare/Principal | 2020-06-01 |
| WAVE LIFE SCIENCES LTD. | Direktör/Styrelseledamot | 2018-01-01 |
| ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Tess Camerons utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 11 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Wave Life Sciences Ltd.
Wave Life Sciences Ltd. BiotechnologyHealth Technology Operates as a biotechnology company that develops RNA oligonucleotides medicines | Health Technology |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cytek Biosciences, Inc.
Cytek Biosciences, Inc. Medical SpecialtiesHealth Technology Operates as a life sciences technology company engages in the provision of cell analysis tools by leveraging novel technical approaches | Health Technology |
Foghorn Therapeutics, Inc.
Foghorn Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops novel drugs to treat cancer and other serious medical disorders | Health Technology |
Medical Microinstruments SpA
Medical Microinstruments SpA Medical SpecialtiesHealth Technology Develops and manufactures surgical micro-instruments | Health Technology |
RA Capital Management LP (Private Equity)
RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of healthcare and life sciences. It provides financing for pre-seed, seed stage, early stage and growth capital requirements . The firm acts as a lead and co-investor, makes follow-on investments and has a board seat requirement. | Finance |
Nodexus, Inc.
Nodexus, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company which commercializing the one platform to address widespread unmet needs | Commercial Services |
Avilar Therapeutics, Inc.
Avilar Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops covalent drugs to treat cancer and other autoimmune diseases | Commercial Services |
Research Alliance Corp. II
Research Alliance Corp. II Financial ConglomeratesFinance Operates as a blank check company | Finance |
Research Alliance Holdings II LLC |
















